Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'INFECTED PATIENTS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1584 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Skiest, DJ
      Focal neurological disease in patients with acquired immunodeficiency syndrome

      CLINICAL INFECTIOUS DISEASES
    2. Andreoletti, L; Lescieux, A; Lambert, V; Si-Mohamed, A; Matta, M; Wattre, P; Belec, L
      Semiquantitative detection of JCV-DNA in peripheral blood leukocytes from HIV-1-Infected patients with or without Progressive Multifocal Leukoencephalopathy

      JOURNAL OF MEDICAL VIROLOGY
    3. Midulla, F; Strappini, P; Sandstrom, T; Bjermer, L; Falasca, C; Capocaccia, P; Catania, S; Soldi, E; Villa, MP; Ronchetti, R
      Cellular and noncellular components of bronchoalveolar lavage fluid in HIV-1-infected children with radiological evidence of interstitial lung damage

      PEDIATRIC PULMONOLOGY
    4. Salmaggi, A; Maccagnano, E; Castagna, A; Zeni, S; Fantini, F; Cinque, P; Savoiardo, M
      Reversal of CSF positivity for JC virus genome by cidofovir in a patient with systemic lupus erythematosus and progressive multifocal leukoencephalopathy

      NEUROLOGICAL SCIENCES
    5. Rosen, HR
      Hepatitis B and C in the liver transplant recipient: Current understandingand treatment

      LIVER TRANSPLANTATION
    6. Akeb, F; Creminon, C; Grassi, J; Guedj, R; Duval, D
      The production and evaluation of antibodies for enzyme immunoassay of AZTTP

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    7. Meroni, L; Manganaro, D; Varchetta, S; Gatti, N; Riva, A; Monforte, AD; Galli, M
      Maintenance of naive and Th1CD4 phenotype and lack of CD8 activation in patients switching from protease inhibitors to nonnucleoside reverse transcriptase inhibitor-based antiretroviral regimens

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    8. Servais, J; Nkoghe, T; Schmit, JC; Arendt, V; Robert, I; Staub, T; Moutschen, M; Schneider, F; Hemmer, R
      HIV-associated hematologic disorders are correlated with plasma viral loadand improve under highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    9. Carrieri, P; Cailleton, V; Le Moing, V; Spire, B; Dellamonica, P; Bouvet, E; Raffi, F; Journot, V; Moatti, JP
      The dynamic of adherence to highly active antiretroviral therapy: Results from the French National APROCO cohort

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    10. Monforte, AD; Bugarini, R; Pezzotti, P; De Luca, A; Antinori, A; Mussini, C; Vigevani, GM; Tirelli, U; Bruno, R; Gritti, F; Piazza, M; Chigiotti, S; Chirianni, A; De Stefano, C; Pizzigallo, E; Perrella, O; Moroni, M
      Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    11. Lafeuillade, A; Poggi, C; Chadapaud, S; Hittinger, G; Chouraqui, M; Delbeke, E
      HIV-1 induction-maintenance at the lymph node level: The "Apollo-97" study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    12. Dieleman, JP; Salahuddin, S; Hsu, YS; Burger, DM; Gyssens, IC; Sturkenboom, MCJM; Stricker, BHC; Kok, DJ
      Indinavir crystallization around the loop of Henle: Experimental evidence

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    13. Tozzi, V; Balestra, T; Galgani, S; Narciso, P; Sampaolesi, A; Antinori, A; Giulianelli, M; Serraino, I; Ippolito, G
      Changes in neurocognitive performance in a cohort of patients treated withHAART for 3 years

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    14. Altice, FL; Mostashari, F; Friedland, GH
      Trust and the acceptance of and adherence to antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    15. Nunez, M; Lana, R; Mendoza, JL; Martin-Carbonero, L; Soriano, V
      Risk factors for severe hepatic injury after introduction of highly activeantiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    16. Lucia, MB; Rutella, S; Leone, G; Vella, S; Cauda, R
      HIV-protease inhibitors contribute to P-glycoprotein efflux function defect in peripheral blood lymphocytes from HIV-positive patients receiving HAART

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    17. Veldkamp, AI; van Heeswijk, RPG; Mulder, JW; Meenhorst, PL; Schreij, G; van der Geest, S; Lange, JMA; Beijnen, JH; Hoetelmans, RMW
      Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individuals

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    18. Jensen-Fangel, S; Thomsen, HF; Larsen, L; Black, FT; Obel, N
      The effect of nevirapine in combination with nelfinavir in heavily pretreated HIV-1-infected patients - A prospective, open-label, controlled, randomized study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    19. Marimoutou, C; Chene, G; Mercie, P; Neau, D; Farbos, S; Morlat, P; Ceccaldi, J; Dabis, F
      Prognostic factors of combined viral load and CD4(+) cell count responses under triple antiretroviral therapy, aquitaine cohort, 1996-1998

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    20. Coull, JJ; Turner, D; Melby, T; Betts, MR; Lanier, R; Margolis, DM
      A pilot study of the use of mycophenolate mofetil as a component of therapy for multidrug-resistant HIV-1 infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    21. Bangsberg, DR; Hecht, FM; Clague, H; Charlebois, ED; Ciccarone, D; Chesney, M; Moss, A
      Provider assessment of adherence to HIV antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    22. Sabin, CA; Fisher, M; Churchill, D; Pozniak, A; Hay, P; Easterbrook, P; Williams, I
      Long-term follow-up of antiretroviral-naive HIV-positive patients treated with nevirapine

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    23. Shuter, J; Chang, CJ; Klein, RS
      Prevalence and predictive value of overweight in an urban HIV care clinic

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    24. Nasti, G; di Gennaro, G; Rizzardini, G; Cadorin, L; Tirelli, U
      Chronic hepatitis C in HIV-coinfected patients: Feasibility and efficacy of interferon-alpha 2b and ribavirin combination therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    25. Lafeuillade, A; Poggi, C; Chadapaud, S; Hittinger, G; Chouraqui, M; Pisapia, M; Delbeke, E
      Pilot study of a combination of highly active antiretroviral therapy and cytokines to induce HIV-1 remission

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    26. Kleeberger, CA; Phair, JP; Strathdee, SA; Detels, R; Kingsley, L; Jacobson, LP
      Determinants of heterogeneous adherence to HIV-antiretroviral therapies inthe multicenter AIDS cohort study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    27. Loveday, C
      Nucleoside reverse transcriptase inhibitor resistance

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    28. Saves, M; Morlat, P; Chene, G; Peuchant, E; Pellegrin, I; Bonnet, F; Bernard, N; Lacoste, D; Salamon, R; Beylot, J
      Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination antiretroviral therapy

      CLINICAL IMMUNOLOGY
    29. Sasadeusz, J
      Human immunodeficiency virus-hepatitis C coinfection: swapping new problems for newer ones

      INTERNAL MEDICINE JOURNAL
    30. Flepp, M; Schiffer, V; Weber, R; Hirschel, B
      Modern anti-HIV therapy

      SWISS MEDICAL WEEKLY
    31. Caspari, G
      Reporting of infected patients according to the new law 'Infektionsschutzgesetz' in transfusion medicine

      INFUSION THERAPY AND TRANSFUSION MEDICINE-INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
    32. Pierce, AB; Hoy, JF
      Is the recommendation for pneumococcal vaccination of HIV patients evidence based?

      JOURNAL OF CLINICAL VIROLOGY
    33. Price, P; Mathiot, N; Krueger, R; Stone, S; Keane, NM; French, MA
      Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy

      JOURNAL OF CLINICAL VIROLOGY
    34. Pett, SL; Emery, S
      Immunomodulators as adjunctive therapy for HIV-1 infection

      JOURNAL OF CLINICAL VIROLOGY
    35. Garcia-Lerma, JG; Heneine, W
      Resistance of human immunodeficiency virus type 1 to reverse transcriptaseand protease inhibitors: genotypic and phenotypic testing

      JOURNAL OF CLINICAL VIROLOGY
    36. Zoulim, F
      Detection of hepatitis B virus resistance to antivirals

      JOURNAL OF CLINICAL VIROLOGY
    37. Elbim, C; Pillet, S; Prevost, MH; Preira, A; Girard, PM; Rogine, N; Hakim, J; Israel, N; Gougerot-Pocidalo, MA
      The role of phagocytes in HIV-related oxidative stress

      JOURNAL OF CLINICAL VIROLOGY
    38. Lasker, BA; Elie, CM; Lott, TJ; Espinel-Ingroff, A; Gallagher, L; Kuykendall, RJ; Kellum, ME; Pruitt, WR; Warnock, DW; Rimland, D; Mcneil, MM; Reiss, E
      Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visits

      MEDICAL MYCOLOGY
    39. Le Monte, AM; Goldman, M; Smedema, ML; Connolly, PA; McKinsey, DS; Cloud, GA; Kauffman, CA; Wheat, LJ
      DNA fingerprinting of serial Candida albicans isolates obtained during itraconazole prophylaxis in patients with AIDS

      MEDICAL MYCOLOGY
    40. Badoc, C; Bertout, S; Mallie, M; Bastide, JM
      Genotypic identification of Candida dubliniensis isolated from HIV patients by MLEE

      MEDICAL MYCOLOGY
    41. White, AJ
      Mitochondrial toxicity and HIV therapy

      SEXUALLY TRANSMITTED INFECTIONS
    42. Taylor, S; Pereira, AS
      Antiretroviral drug concentrations in semen of HIV-1 infected men

      SEXUALLY TRANSMITTED INFECTIONS
    43. Nieuwkerk, P; Gisolf, E; Sprangers, M; Danner, S
      Adherence over 48 weeks in an antiretroviral clinical trial: variable within patients, affected by toxicities and independently predictive of virological response

      ANTIVIRAL THERAPY
    44. John, M; Nolan, D; Mallal, S
      Antiretroviral therapy and the lipodystrophy syndrome

      ANTIVIRAL THERAPY
    45. Vandamme, AM; Houyez, F; Banhegyi, D; Clotet, B; De Schrijver, G; De Smet, KAL; Hall, WW; Harrigan, R; Hellmann, N; Hertogs, K; Holtzer, C; Larder, B; Pillay, D; Race, E; Schmit, JC; Schuurman, R; Shulse, E; Sonnerborg, A; Miller, V
      Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up

      ANTIVIRAL THERAPY
    46. Foudraine, NA; Jurriaans, S; Weverling, GJ; Burger, DM; Hoetelmans, RMW; Roos, MTL; Maas, J; Miedema, F; Reiss, P; Portegies, P; de Wolf, F; Lange, JMA
      Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial

      ANTIVIRAL THERAPY
    47. Squires, KE
      An introduction to nucleoside and nucleotide analogues

      ANTIVIRAL THERAPY
    48. Miller, V; Larder, BA
      Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure

      ANTIVIRAL THERAPY
    49. Hoetelmans, R
      Pharmacological exposure and the development of drug resistance in HIV

      ANTIVIRAL THERAPY
    50. Cinque, P; Pierotti, C; Vigano, MG; Bestetti, A; Fausti, C; Bertelli, D; Lazzarin, A
      The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy

      JOURNAL OF NEUROVIROLOGY
    51. Scully, C; Dios, PD
      Orofacial effects of antiretroviral therapies

      ORAL DISEASES
    52. Hube, B; Naglik, J
      Candida albicans proteinases: resolving the mystery of a gene family

      MICROBIOLOGY-SGM
    53. Pintado, V; Lopez-Velez, R
      HIV-associated visceral leishmaniasis

      CLINICAL MICROBIOLOGY AND INFECTION
    54. Blasco-Navalpotro, M; Jordan, M; Camarena, JJ; Borras, S
      Clinical microbiological case: thermointolerant microorganism growth in blood cultures and catheter tip

      CLINICAL MICROBIOLOGY AND INFECTION
    55. Caro, JJ; O'Brien, JA; Migliaccio-Walle, K; Raggio, G
      Economic analysis of initial HIV treatment - Efavirenz- versus indinavir-containing triple therapy

      PHARMACOECONOMICS
    56. Abbott, KC; Hypolite, I; Welch, PG; Agodoa, LYC
      Human immunodeficiency virus/acquired immunodeficiency syndrome-associatednephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era

      JOURNAL OF NEPHROLOGY
    57. Giammanco, GM; Pecorella, S; Distefano, S; Pecoraro, V; Milici, ME; Pizzo, G
      Fluconazole susceptibility of Italian Candida dabliniensis clinical isolates determined by reference and simplified tests

      MICROBIOLOGICA
    58. Meredith, KL; Jeffe, DB; Mundy, LM; Fraser, VJ
      Sources influencing patients in their HIV medication decisions

      HEALTH EDUCATION & BEHAVIOR
    59. Polsky, B; Kotler, D; Steinhart, C
      HIV-associated wasting in the HAART era: Guidelines for assessment, diagnosis, and treatment

      AIDS PATIENT CARE AND STDS
    60. Knobel, H; Guelar, A; Carmona, A; Espona, M; Gonzalez, A; Lopez-Colomes, JL; Saballs, P; Gimeno, JL; Diez, A
      Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors

      AIDS PATIENT CARE AND STDS
    61. Domingo, P; Fontanet, A
      Management of complications associated with totally implantable ports in patients with AIDS

      AIDS PATIENT CARE AND STDS
    62. Pardo, CA; McArthur, JC; Griffin, JW
      HIV neuropathy: Insights in the pathology of HIV peripheral nerve disease

      JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
    63. Engberg, J; Aarestrup, FM; Taylor, DE; Gerner-Smidt, P; Nachamkin, I
      Quinolone and macrolide resistance in Campylobacter jejuni and C-coli: Resistance mechanisms and trends in human isolates

      EMERGING INFECTIOUS DISEASES
    64. Uchakin, PN; Tobin, B; Cubbage, M; Marshall, G; Sams, C
      Immune responsiveness following academic stress in first-year medical students

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    65. Takii, T; Abe, C; Tamura, A; Ramayah, S; Belisle, JT; Brennan, PJ; Onozaki, K
      Interleukin-1 or tumor necrosis factor-alpha augmented the cytotoxic effect of mycobacteria on human fibroblasts: Application to evaluation of pathogenesis of clinical isolates of Mycobacterium tuberculosis and M-avium complex

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    66. Patton, LL; Bonito, AJ; Shugars, DA
      A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients

      ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS
    67. Chastain, MA; Chastain, JB; Coleman, WP
      HIV lipodystrophy: Review of the syndrome and report of a case treated with liposuction

      DERMATOLOGIC SURGERY
    68. Wootton, JC; Sparber, A
      Surveys of complementary and alternative medicine: Part III. Use of alternative and complementary therapies for HIV/AIDS

      JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE
    69. Burman, WJ; Jones, BE
      Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    70. Sullivan, JH; Mitchell, TJ; Steinhoff, MC
      Antipneumolysin antibody titers in HIV-seropositive injection drug users before and after pneumococcal bacteremia

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    71. Blazevic, V; Jankelevich, S; Steinberg, SM; Jacobsen, F; Yarchoan, R; Shearer, GM
      Highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children: Analysis of cellular immune responses

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    72. Weinberg, A
      In vitro hydroxyurea decreases th1 cell-mediated immunity

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    73. Parsa, M; Walsh, MJ
      Ethics seminars: HIV testing, consent, and physician responsibilities

      ACADEMIC EMERGENCY MEDICINE
    74. Leissinger, CA
      Platelet kinetics in immune thrombocytopenic purpura and human immunodeficiency virus thrombocytopenia

      CURRENT OPINION IN HEMATOLOGY
    75. John, L; Marra, F; Ensom, MHH
      Role of therapeutic drug monitoring for protease inhibitors

      ANNALS OF PHARMACOTHERAPY
    76. Jakob, B; Birkholz, S; Schneider, T; Duchmann, R; Zeitz, M; Stallmach, A
      Immune response to autologous and heterologous Helicobacter pylori antigens in humans

      MICROSCOPY RESEARCH AND TECHNIQUE
    77. Ally, R; Schurmann, D; Kreisel, W; Carosi, G; Aguirrebengoa, K; Dupont, B; Hodges, M; Troke, P; Romero, AJ
      A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients

      CLINICAL INFECTIOUS DISEASES
    78. Villanueva, A; Arathoon, EG; Gotuzzo, E; Berman, RS; DiNubile, MJ; Sable, CA
      A randomized double-blind study of caspofungin versus amphotericin for thetreatment of candidal esophagitis

      CLINICAL INFECTIOUS DISEASES
    79. Kilby, JM
      Human immunodeficiency virus pathogenesis: Insights from studies of lymphoid cells and tissues

      CLINICAL INFECTIOUS DISEASES
    80. McNeil, MM; Nash, SL; Hajjeh, RA; Phelan, MA; Conn, LA; Plikaytis, BD; Warnock, DW
      Trends in mortality due to invasive mycotic diseases in the United States,1980-1997

      CLINICAL INFECTIOUS DISEASES
    81. McNabb, J; Ross, JW; Abriola, K; Turley, C; Nightingale, CH; Nicolau, DP
      Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic

      CLINICAL INFECTIOUS DISEASES
    82. Tudo, G; Gonzalez, J; Gatell, JM; Cayla, JA; Martinez, E; Garcia, A; Navarro, M; Soriano, E; de Anta, MTJ
      Detection of unsuspected cases of nosocomial transmission of tuberculosis by use of a molecular typing method

      CLINICAL INFECTIOUS DISEASES
    83. Duong, M; Piroth, L; Peytavin, G; Forte, F; Kohli, E; Grappin, M; Buisson, M; Chavanet, P; Portier, H
      Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: Relationship to virologic response

      CLINICAL INFECTIOUS DISEASES
    84. Cruciani, M; Malena, M; Bosco, O; Gatti, G; Serpelloni, G
      The impact of human immunodeficiency virus type 1 on infectiousness of tuberculosis: A meta-analysis

      CLINICAL INFECTIOUS DISEASES
    85. Abgrall, S; Rabaud, C; Costagliola, D
      Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era

      CLINICAL INFECTIOUS DISEASES
    86. Driver, CR; Munsiff, SS; Li, JH; Kundamal, N; Osahan, SS
      Relapse in persons treated for drug-susceptible tuberculosis in a population with high coinfection with human immunodeficiency virus in New York City

      CLINICAL INFECTIOUS DISEASES
    87. Warren, DK; Foley, KM; Polish, LB; Seiler, SM; Fraser, VJ
      Tuberculin skin testing of physicians at a midwestern teaching hospital: A6-year prospective study

      CLINICAL INFECTIOUS DISEASES
    88. Sebti, A; Kiehn, TE; Perlin, D; Chaturvedi, V; Wong, M; Doney, A; Park, S; Sepkowitz, KA
      Candida dubliniensis at a cancer center

      CLINICAL INFECTIOUS DISEASES
    89. Fleisch, F; Zbinden, R; Vanoli, C; Ruef, C
      Epidemic spread of a single clone of methicillin-resistant Staphylococcus aureus among injection drug users in Zurich, Switzerland

      CLINICAL INFECTIOUS DISEASES
    90. Narita, M; Hisada, M; Thimmappa, B; Stambaugh, JJ; Ibrahim, E; Hollender, ES; Ashkin, D
      Tuberculosis recurrence: Multivariate analysis of serum levels of tuberculosis drugs, human immunodeficiency virus status, and other risk factors

      CLINICAL INFECTIOUS DISEASES
    91. Sereti, I; Lane, HC
      Immunopathogenesis of human immunodeficiency virus: Implications for immune-based therapies

      CLINICAL INFECTIOUS DISEASES
    92. Shevitz, AH; Knox, TA
      Nutrition in the era of highly active antiretroviral therapy

      CLINICAL INFECTIOUS DISEASES
    93. Walmsley, S; King, S; McGeer, A; Ye, YN; Richardson, S
      Oropharyngeal candidiasis in patients with human immunodeficiency virus: Correlation of clinical outcome with in vitro resistance, serum azole levels, and immunosuppression

      CLINICAL INFECTIOUS DISEASES
    94. Simdon, J; Watters, D; Bartlett, S; Connick, E
      Ototoxicity associated with use of nucleoside analog reverse transcriptaseinhibitors: A report of 3 possible cases and review of the literature

      CLINICAL INFECTIOUS DISEASES
    95. Sacks, LV; Pendle, S; Orlovic, D; Andre, M; Popara, M; Moore, G; Thonell, L; Hurwitz, S
      Adjunctive salvage therapy with inhaled aminoglycosides for patients with persistent smear-positive pulmonary tuberculosis

      CLINICAL INFECTIOUS DISEASES
    96. Roemer, E; Blau, IW; Basara, N; Kiehl, MG; Bischoff, M; Gunzelmann, S; Kirsten, D; Sanchez, H; Wocker, EL; Fauser, AA
      Toxoplasmosis, a severe complication in allogeneic hematopoietic stem celltransplantation: Successful treatment strategies during a 5-year single-center experience

      CLINICAL INFECTIOUS DISEASES
    97. Bersoff-Matcha, SJ; Miller, WC; Aberg, JA; van der Horst, C; Hamrick, HJ; Powderly, WG; Mundy, LM
      Sex differences in nevirapine rash

      CLINICAL INFECTIOUS DISEASES
    98. Shiboski, CH; Wilson, CM; Greenspan, D; Hilton, J; Greenspan, JS; Moscicki, AB
      HIV-related oral manifestations among adolescents in a multicenter cohort study

      JOURNAL OF ADOLESCENT HEALTH
    99. Stylianou, E; Aukrust, P; Muller, F; Nordoy, I; Froland, SS
      Complex effects of interferon-alpha on the cytokine network in HIV infection - Possible contribution to immunosuppression

      CYTOKINE
    100. Zhou, P; Lee, J; Moore, P; Brasky, KM
      High-efficiency gene transfer into rhesus macaque primary T lymphocytes bycombining 32 degrees C centrifugation and CH-296-coated plates: Effect of gene transfer protocol on T cell homing receptor expression

      HUMAN GENE THERAPY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/06/20 alle ore 22:28:44